Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients

被引:43
作者
Distel, Luitpold V. R.
Neubauer, Susann
Keller, Ulrike
Sprung, Carl N.
Sauer, Rolf
Grabenbauer, Gerhard G.
机构
[1] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany
[2] Univ Melbourne, Div Res, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia
关键词
chromosomal aberrations; cancer patients; ATM; NBS1; individual sensitivity; cancer risk;
D O I
10.1016/j.radonc.2006.10.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radiosensitivity of normal tissue is a crucial factor of radiotherapy (RT)-related side effects. Here, we report the analysis of spontaneous and in vitro irradiation-induced chromosomal aberrations in 256,679 metaphases from 222 different individuals using three-color fluorescence in situ hybridization as a measure of radiosensitivity. Materials and methods: Samples were categorized into the following 6 groups: (1) healthy individuals, (2) cancer patients prior to radiotherapy, (3) RT-treated cancer patients, (4) individuals heterozygous or (5) homozygous for a mutation in the ataxia telangiectasia mutated (ATM) gene or in the Nijmegen breakage syndrome (NBS1) gene and (6) hypersensitive patients (outliers). Results: A normal distribution of the number of chromosomal aberrations, measured as breaks per metaphase (B/m), was adopted for all examined groups. The mean value of the control group was 0.40 B/m (SD +/- 0.07). This value was lower compared to the mean breakage rate from 175 non-exposed (0.50 +/- 0.12 B/m) and pre-exposed (0.50 +/- 0.16 B/m) cancer patients. Nineteen of the metaphase spreads from the analyzed cancer patients had a high number of chromosomal aberrations (1.04 +/- 0.29 B/m) and were designated as a separate hypersensitive subgroup (outliers). The aberration frequency of this group was comparable to those of ATM or NBS1 heterozygotes (0.86 +/- 0.26 B/m). The highest incidence of aberrations was observed in ATM and NBS1 homozygous patients (2.23 +/- 1.03 B/m). Conclusion: The frequency of break events in the analyzed groups resulted in a normal distribution with varying means and broadnesses defining a characteristic sensitivity pattern for each group. In the RT-relevant group of cancer patients, those patients who have cancer, about one-third of the normally distributed samples were determined to be sensitive as defined by the number of induced aberrations higher than the 99% confidence interval of the normal individual's Gaussian distribution. About 5% of these samples were outside of the 99% confidence interval for the RT-relevant group's normal distribution. These outliers with higher chromosomal breakage rates suggest a unique class of hypersensitive individuals that are susceptible to chromosomal damage and may be directly associated with an increased risk to suffer from radiotherapy-related complications. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 37 条
[1]   Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition [J].
Baeyens, A ;
Thierens, H ;
Claes, K ;
Poppe, B ;
Messiaen, L ;
De Ridder, L ;
Vral, A .
BRITISH JOURNAL OF CANCER, 2002, 87 (12) :1379-1385
[2]   Chromosomal radiosensitivity as a marker of predisposition to common cancers? [J].
Baria, K ;
Warren, C ;
Roberts, SA ;
West, CM ;
Scott, D .
BRITISH JOURNAL OF CANCER, 2001, 84 (07) :892-896
[3]   Ataxia-telangiectasia: Phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity [J].
Becker-Catania, SG ;
Chen, G ;
Hwang, MJ ;
Wang, ZJ ;
Sun, X ;
Sanal, O ;
Bernatowska-Matuszkiewicz, E ;
Chessa, L ;
Lee, EYHP ;
Gatti, RA .
MOLECULAR GENETICS AND METABOLISM, 2000, 70 (02) :122-133
[4]   AN INTER-NORDIC PROSPECTIVE-STUDY ON CYTOGENETIC ENDPOINTS AND CANCER RISK [J].
BROGGER, A ;
HAGMAR, L ;
HANSTEEN, IL ;
HEIM, S ;
HOGSTEDT, B ;
KNUDSEN, L ;
LAMBERT, B ;
LINNAINMAA, K ;
MITELMAN, F ;
NORDENSON, I ;
REUTERWALL, C ;
SALOMAA, S ;
SKERFVING, S ;
SORSA, M .
CANCER GENETICS AND CYTOGENETICS, 1990, 45 (01) :85-92
[5]  
Burnet NG, 1998, INT J CANCER, V79, P606, DOI 10.1002/(SICI)1097-0215(19981218)79:6<606::AID-IJC9>3.0.CO
[6]  
2-Y
[7]   IDENTIFICATION OF ATAXIA TELANGIECTASIA HETEROZYGOTES, A CANCER PRONE POPULATION [J].
CHEN, PC ;
LAVIN, MF ;
KIDSON, C ;
MOSS, D .
NATURE, 1978, 274 (5670) :484-486
[8]   Ataxia-telangiectasia, an evolving phenotype [J].
Chun, HH ;
Gatti, RA .
DNA REPAIR, 2004, 3 (8-9) :1187-1196
[9]   Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed [J].
Dikomey, E ;
Borgmann, K ;
Peacock, J ;
Jung, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :1194-1200
[10]   Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome [J].
Distel, L ;
Neubauer, S ;
Varon, R ;
Holter, W ;
Grabenbauer, G .
MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (01) :44-48